Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 5:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 1,740 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Device Arm Clear all

Conditions: Gastric Cancer, Chemotherapy, Adjuvant, Peritoneal Metastases, Minimally Invasive Surgical Procedures
Interventions: Cisplatin, Doxorubicin; Drug
Lead sponsor: Odense University Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Skin Inflammation, Acne, Skin Diseases, Dermatological Non-Disease, Skin Condition, Eczema
Interventions: Joovv Mini; Device
Lead sponsor: ProofPilot; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Infertility, Male Infertility, InVitro Fertilization, Aneuploidy Rate, Euploidy Rate
Interventions: microfludics semen processing device; Device
Lead sponsor: MotilityCount aps; Industry
Eligibility: 21 Years to 45 Years
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Heart Failure
Interventions: Alleviant ALV1 System, Sham-Control; Device · Other
Lead sponsor: Alleviant Medical, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2032
U.S. locations: 56
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 50 more

Conditions: Age Related Macular Degeneration
Interventions: ForeseeHome AMD Monitoring Device; Diagnostic Test
Lead sponsor: Notal Vision Ltd.; Industry
Eligibility: 55 Years and older
Enrollment: 1,520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 38
States / cities: Little Rock, Arkansas • La Jolla, California • Loma Linda, California + 33 more

Conditions: Hearing Impaired
Interventions: ciPDA; Device
Lead sponsor: Philip Loizou; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Lumbar Disc Herniation
Interventions: Lumbar discectomy Open, Lumbar discectomy Endoscopic; Procedure
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pain, Chronic, Failed Back Surgery Syndrome
Interventions: Burst-SCS, Sham SCS; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Asthma
Interventions: Lyophilized mepolizumab, Liquid mepolizumab, Prefilled autoinjector, Prefilled Safety Syringe; Biological · Device
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 246 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Postoperative Care
Interventions: Education regarding ambulation, Ambulation reminder alarms, Fitbit; Behavioral · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Uncontrolled Hypertension
Interventions: RPD, Active hypertension medical therapy; Device · Drug
Lead sponsor: Verve Medical, Inc; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 9
States / cities: Birmingham, Alabama • Surprise, Arizona • Los Angeles, California + 6 more

Conditions: Sexual Dysfunction, Physiological, Body Image, Libido; Loss, Aversion
Interventions: Hypnotic Relaxation Intervention (HRI), Vulvovaginal Atrophy (VVA); Other · Device
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Postoperative Pain, Acute, Postoperative Depression, Anxiety, Sleep Disturbance, Malignant Female Reproductive System Neoplasm
Interventions: eHealth Mindful Movement and Breathing, Life Impacts Reflection, PROMIS Questionnaires; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Charlotte, North Carolina • Winston-Salem, North Carolina

Conditions: Endometriosis
Interventions: Ultravision™ Visual Field Clearing System, Ultravision Ionwand™; Device
Lead sponsor: Mercy Research; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive
Interventions: Aortix System; Device
Lead sponsor: Procyrion; Industry
Eligibility: 21 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 49
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Concord, California + 37 more

Conditions: Post Partum Haemorrhage, Maternal Care Patterns, High Risk Pregnancy
Interventions: Oli is a non-invasive, wearable device, designed to provide clinicians with an early indication if the participant is at a higher risk of developing abnormal postpartum uterine bleeding; Device
Lead sponsor: Baymatob Operations Pty Ltd; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Denver, Colorado • Baton Rouge, Louisiana • New York, New York + 2 more

Conditions: First Trimester Abortion, Virtual Reality
Interventions: applied VR headset; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lumbar Spinal Stenosis
Interventions: Interspinous Fusion; Device
Lead sponsor: Pacific Research Institute; Network
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 10
States / cities: Santa Rosa, California • Jupiter, Florida • Slidell, Louisiana + 6 more

Conditions: COVID 19
Interventions: ensoETM device; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type 1 Diabetes
Interventions: Cognitive Behavioral Therapy for Diabetes Distress (CBT-DD) with Continuous Glucose Monitoring, Continuous Glucose Monitoring (CGM); Behavioral · Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: HIV, Adolescent Behavior, Gender
Interventions: Male-Specific Intervention Package, Female-Specific Intervention Package, Pre-Exposure Prophylaxis (Females), Cash Transfer Cohort (Females); Other · Drug · Behavioral
Lead sponsor: New York University; Other
Eligibility: 15 Years to 24 Years
Enrollment: 1,215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma
Interventions: Collaborative Agenda-Setting Intervention; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: 4mm x 32G pen needle, 8mm x 31G pen needle, 5mm x 31G pen needle; Device
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 4
States / cities: Birmingham, Alabama • Escondido, California • Atlanta, Georgia + 1 more

Conditions: Sleep Deprivation, Insufficient Sleep Syndrome, Healthy
Interventions: PowerSleep Stim, PowerSleep Sham; Device
Lead sponsor: Philips Respironics; Industry
Eligibility: 21 Years to 50 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 7
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Lehigh Acres, Florida + 4 more

Search by objective public record fields.

The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.

Joovvin' for Your Skin Health Study

To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.

Alleviant ALLAY-HF Study

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device

Cochlear Implant PDA Based Research Platform

Full-Endoscopic vs Open Discectomy for the Treatment of Symptomatic Lumbar Herniated Disc

Burst Spinal Cord Stimulation (Burst-SCS) Study

A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

Fitbit for Postoperative Ambulation

Renal Pelvic Denervation Pilot Trial

Women's Interventions for Sexual Health: WISH

REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

Virtual Reality Experience in First Trimester D&C

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Core Warming of COVID-19 Patients

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

A Study of the Effectiveness and Efficacy of the PowerSleep Device